Recurrent herpes simplex in elderly with vitiligo vulgaris: A dilemmatic case
DOI:
https://doi.org/10.66344/jpad.v32i4.1993Abstract
Herpes simplex is a viral infection that frequently recurs after treatment. We reported a case of recurrent herpetic lesion in a 61 year old elderly with vitiligo that routinely undergoes UVB phototherapy. The patient was previously diagnosed with vitiligo vulgaris and is already under narrowband UVB phototherapy since 18 months ago. The herpetic lesion appeared above the vitiligo area, therefore it was well-exposed to UVB phototherapy. There was no other disease or drug consumed. Upon treatment with oral and topical acyclovir, the herpetic lesion improved. Not long after however, the lesion continued to reappear after treatment, up to five times in the past year. Therefore, we increased the dose of acyclovir to 800 mg b.i.d. for 7 days, and protected the herpetic lesion during phototherapy until it resolved. Suggested treatment options include higher and longer periods of antiviral, herpetic lesion protection, and/or surgical nerve decompression.
References
1. Bansal RI, Tutrone WD, Weinberg JM. Viral skin infections in the elderly: diagnosis and management. Drugs Aging. 2002;19(7):503-14.
2. Marques AR, Cohen JI. Herpes simplex. Dalam: Goldsmith LA, Katz SI, GIlchrest BA, Paller AS, Leffell DJ, Wolff K, editor. Fitzpatricks’s dermatology in general medicine. Edisi ke-8. McGraw-Hill; 2012.2367-82.
3. Birlea SA, Spritz RA, Norris DA. Vitiligo. Dalam: Goldsmith LA, Katz SI, GIlchrest BA, Paller AS, Leffell DJ, Wolff K, editor. Fitzpatricks’s dermatology in general medicine. Edisi ke-8. McGraw-Hill; 2012. 792-803.
4. Jung SY. Lee JH, Kim GM, Bae JM. Reactivation of herpes simplex virus secondary to excimer laser treatment in a patient with vitiligo. Ann Dermatol. 2017; 29(4):493–4.
5. Elston DM. Antiviral drugs. Dalam: Goldsmith LA, Katz SI, GIlchrest BA, Paller AS, Leffell DJ, Wolff K, editor. Fitzpatricks’s dermatology in general medicine. Edisi ke-8. McGraw-Hill; 2012. 2787-96.
6. Evans TG, Bernstein DI, Raborn GW, et al. Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis. Antimicrob Agents Chemother. 2002;46(6):1870-4.
7. Bernstein DI, Schleupner CJ, Evans TG, et al. Effect of foscarnet cream on experimental UV radiation-induced herpes labialis. Antimicrob Agents Chemother. 1997;41(9):1961-4.
8. Raborn GW, Martel AY, Grace MG, McGaw WT. Oral acyclovir in prevention of herpes labialis. A randomized, double-blind, multi-centered clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85(1):55-9.
9. Morison WL. Phototerapy and photochemotherapy of skin disease. Edisi ke-3. Taylor & Francis; 2005:195-204.
10. Cafardi JA, Pollack BP, Elmets CA. Phototerapy. Dalam: Goldsmith LA, Katz SI, GIlchrest BA, Paller AS, Leffell DJ, Wolff K, editor. Fitzpatricks’s dermatology in general medicine. Edisi ke-8. McGraw-Hill; 2012. h.2841-50.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Novita Suprapto, dr. Lili Legiawati, dr. Rinadewi Astriningrum, dr. Shannaz Nadia Yusharyahya
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
